drugset / Trial / NCT03431337

Treatment of Acute Sinusitis With High-Dose vs. Standard-Dose Amoxicillin/Clavulanate

NCT03431337 ↗

Phase 4 Terminated 157 enrolled Paul Sorum, MD
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Comparative-effectiveness study of the treatment of acute bacterial sinusitis with amoxicillin/clavulanate 875mg/125mg bid for 7 days with or without the addition of immediate-release amoxicillin 875 mg bid x 7 days. .

Timeline

Start
2018-02-26
Primary completion
2020-05-31
Completion
2020-05-31

Outcome

Missed primary endpoint

Stopped: “Futility found by interim analysis”

paper for a difference of -7.9% (95% CI, -24.4% to 8.5%; P = .35). PMID 33755168 ↗

paper adults treated for clinically diagnosed acute sinusitis did not appear to benefit from taking high-dose compared with standard-dose amoxicillin plus clavulanate. PMID 33755168 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 875 mg —

Indications